{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T17:50:06Z","timestamp":1762710606702},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1991,12,1]],"date-time":"1991-12-01T00:00:00Z","timestamp":691545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[1991,12]]},"DOI":"10.1378\/chest.100.6.1503","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T18:28:23Z","timestamp":1194460103000},"page":"1503-1506","source":"Crossref","is-referenced-by-count":27,"title":["The Safety and Efficacy of Clarithromycin in Patients with Legionella Pneumonia"],"prefix":"10.1016","volume":"100","author":[{"given":"Barviz","family":"Hamedani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juzar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleem","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Romeo","family":"Bachand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghaffar","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafi","family":"Quereshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubina","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafar","family":"Yab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.100.6.1503_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1185\/03007998909110462","article-title":"Acute and chronic Legionnaires disease and co-existent tuberculosis: a trial of erythromycin","volume":"11","author":"Hamedani","year":"1989","journal-title":"Curr Med Res Opin"},{"key":"10.1378\/chest.100.6.1503_bib2","first-page":"1190","article-title":"Delayed seroconversion, Legionnaire's disease, and age [letter]","volume":"2","author":"Hamedani","year":"1988","journal-title":"Lancet"},{"key":"10.1378\/chest.100.6.1503_bib3","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/AAC.32.11.1710","article-title":"Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides","volume":"32","author":"Hardy","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.100.6.1503_bib4","unstructured":"Garcia-de-Lomas J, Munoz C, Escoms R, Munoz I, Climent MT. Activity of clarithromycin against 100 Legionella pneumophila sero-group 1 isolates [abstract]. Read before the Seventh Mediterranean Congress of Chemotherapy, Barcelona, Spain, 1990"},{"key":"10.1378\/chest.100.6.1503_bib5","unstructured":"Fernandes PB, Freiberg LA. Antibacterial activity of N-demethyl and 14-hydroxy metabolites of A-56268 (TE-031) (abstract 408). Read before the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Sept 28-Oct 1, 1986"},{"key":"10.1378\/chest.100.6.1503_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0738-1751(87)90002-5","article-title":"The macrolide revival: thirty-five years after erythromycin","volume":"4","author":"Fernandes","year":"1987","journal-title":"Antimicrob Newsletter"},{"key":"10.1378\/chest.100.6.1503_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/AAC.31.2.343","article-title":"In vitro activity of a new macrolide A-56268, compared with that of roxithromycin, erythromycin, and clindamycin","volume":"31","author":"Barry","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.100.6.1503_bib8","unstructured":"Sennello LT, Chu S-Y, Wilson DS, Lows KS, Bunnell ST, Varga LL, Snyder KM. Single dose pharmacokinetics of Abbott-56268 (TE-031) after oral dosing. Presented at the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Sept 28-Oct 1, 1986"},{"key":"10.1378\/chest.100.6.1503_bib9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/AAC.33.9.1419","article-title":"New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy","volume":"33","author":"Kirst","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1378\/chest.100.6.1503_bib10","unstructured":"Suwa T, Yoshida H, Kohno Y, Fukushima K, Kobayashi H. High distribution of TE-031 (A-56268), a new macrolide antibiotic, in the lung (abstract 417). Read before the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Sept 28-Oct 1, 1986"},{"key":"10.1378\/chest.100.6.1503_bib11","first-page":"441","article-title":"Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models","volume":"14","author":"Fernandes","year":"1988","journal-title":"Drugs Under Clinical and Experimental Research"},{"key":"10.1378\/chest.100.6.1503_bib12","first-page":"229","article-title":"Legionella pneumophila: laboratory diagnosis in developing countries like Pakistan","volume":"39","author":"Hafiz","year":"1989","journal-title":"J Pakistan Med Assn"},{"key":"10.1378\/chest.100.6.1503_bib13","series-title":"Coding symbols for thesaurus of adverse reaction terms","author":"COSTART","year":"1985"},{"key":"10.1378\/chest.100.6.1503_bib14","series-title":"SAS user's guide: basics, version","first-page":"1","author":"SAS Institute Inc","year":"1985"},{"key":"10.1378\/chest.100.6.1503_bib15","unstructured":"Bachand R, Lumpkin MM, Sebree TB. Open study of clarithromycin in the treatment of outpatients with acute lower respiratory tract infections. Read before the Panamerican Congress of Infectious Diseases, Caracas Venezuela, February 22, 1989"},{"issue":"suppl 3","key":"10.1378\/chest.100.6.1503_bib16","first-page":"548","article-title":"TE-031 (A-56268) in the treatment of respiratory tract infections","volume":"36","author":"Aonuma","year":"1988","journal-title":"Chemotherapy"},{"issue":"suppl 3","key":"10.1378\/chest.100.6.1503_bib17","first-page":"553","article-title":"Clinical examination of TE-031 (A-56268) in respiratory tract infection","volume":"36","author":"Hayashi","year":"1988","journal-title":"Chemotherapy"},{"issue":"suppl 3","key":"10.1378\/chest.100.6.1503_bib18","first-page":"A850","article-title":"Comparison of gastrointestinal side effects of erythromycin, roxythromycin and clarithromycin (Abbott-56268)","volume":"3","author":"Otterson","year":"1989","journal-title":"Fed Am Soc Exp Biol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216527834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216527834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T04:21:11Z","timestamp":1546489271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216527834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,12]]}},"alternative-id":["S0012369216527834"],"URL":"https:\/\/doi.org\/10.1378\/chest.100.6.1503","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1991,12]]}}}